AMYLYX PHARMACEUTICALS INC's ticker is and the CUSIP is 03237H101. A total of 123 filers reported holding AMYLYX PHARMACEUTICALS INC in Q2 2024. The put-call ratio across all filers is 4.38 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $8,025,539 | -47.2% | 4,223,968 | -21.0% | 0.00% | – |
| Q1 2024 | $15,188,715 | -80.4% | 5,348,139 | +1.4% | 0.00% | -100.0% |
| Q4 2023 | $77,656,332 | -16.0% | 5,275,566 | +4.5% | 0.00% | 0.0% |
| Q3 2023 | $92,466,964 | -13.0% | 5,050,080 | +2.5% | 0.00% | -33.3% |
| Q2 2023 | $106,251,491 | -23.7% | 4,925,892 | +3.8% | 0.00% | -25.0% |
| Q1 2023 | $139,286,986 | -13.5% | 4,747,341 | +8.9% | 0.00% | 0.0% |
| Q4 2022 | $161,046,279 | +62.8% | 4,358,492 | +24.0% | 0.00% | +33.3% |
| Q3 2022 | $98,929,000 | +416.7% | 3,514,356 | +253.6% | 0.00% | +200.0% |
| Q2 2022 | $19,145,000 | +50.2% | 994,001 | +0.2% | 0.00% | – |
| Q1 2022 | $12,750,000 | – | 992,188 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alpha Wave Global, LP | 853,262 | $18,404,861 | 12.06% |
| Stonepine Capital Management, LLC | 1,121,028 | $24,180,574 | 8.72% |
| GREAT POINT PARTNERS LLC | 968,795 | $20,896,908 | 4.09% |
| Ghost Tree Capital, LLC | 550,000 | $11,863,500 | 3.92% |
| Perceptive Advisors | 4,873,919 | $105,130,433 | 3.04% |
| Altium Capital Management LP | 185,000 | $3,990,450 | 3.02% |
| Boxer Capital, LLC | 2,084,000 | $44,952 | 2.08% |
| SECTORAL ASSET MANAGEMENT INC | 387,310 | $8,354,277 | 1.39% |
| AlphaCentric Advisors LLC | 108,000 | $2,329,560 | 1.29% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 680,035 | $14,668,355 | 0.80% |